Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05339139 · ClinicalTrials.gov registry record · Phase 3

SAfety of Regional Citrate Anticoagulation (SARCA Study)

A Phase 3 study of Acute Kidney Injury and ESRD, sponsored by Fresenius Medical Care North America.

Recruiting
Registry status
Phase 3
Development phase
50
Enrollment target
10
Study locations

NCT05339139 is a Phase 3 study of Acute Kidney Injury and ESRD that is actively recruiting participants, run by Fresenius Medical Care North America. The registered enrollment target is 50 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05339139, a Phase 3 study of Acute Kidney Injury and ESRD, is actively recruiting participants, sponsored by Fresenius Medical Care North America.

RECRUITING
Registry status
Phase 3
Development phase
50 participants
Enrollment target
10
Study locations

Study Summary

This is an Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO system in Adult Patients Requiring Continuous Renal Replacement Therapy (SARCA Study).

Conditions Studied

Acute Kidney Injury ESRD

Interventions

  • COMBINATION_PRODUCT Dialysis

Study Locations (10)

Arkansas

  • John L. McClellan Memorial Veterans' Hospital - Little Rock
  • University of Arkansas for Medical Sciences (UAMS) - Little Rock

Michigan

  • University of Michigan - Ann Arbor
  • Henry Ford Hospital - Detroit

Florida

  • Advent Health Orlando - Orlando

Massachusetts

  • UMass Memorial Medical Center - Worcester

Minnesota

  • Mayo Clinic - Rochester

Mississippi

  • University of Mississippi Medical Center - Jackson

Missouri

  • Washington University - Hospital - St Louis

Utah

  • Intermountain Health - Murray

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-10-17
Est. Completion 2025-07-31
Phase Phase 3

Sponsor

Fresenius Medical Care North America

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05339139

The ClinicalTrials.gov registry entry for NCT05339139 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The listed sponsor is Fresenius Medical Care North America, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Dialysis is the first listed.

NCT05339139 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Arkansas, Michigan, Florida.

Frequently Asked Questions

What is clinical trial NCT05339139 about?

NCT05339139 is a clinical study titled "SAfety of Regional Citrate Anticoagulation (SARCA Study)". This is an Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO system in Adult Patients Requiring Continuous Renal Replacement Therapy (SARCA Study).

What is the current status of trial NCT05339139?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2023-10-17. Estimated completion is 2025-07-31.

What conditions does trial NCT05339139 study?

This clinical trial studies the following conditions: Acute Kidney Injury, ESRD.

What interventions are being tested in trial NCT05339139?

The interventions under investigation include: Dialysis (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05339139?

This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05339139 being conducted?

This trial has 10 study locations across Arkansas, Florida, Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Kidney Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Kidney Injury

All registered trials for this condition

ESRD

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.